These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 27150852
1. The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome. Koçak E, Akbal E, Köklü S, Ergül B, Can M. Intern Med; 2016; 55(9):1043-8. PubMed ID: 27150852 [Abstract] [Full Text] [Related]
2. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. Belmonte L, Beutheu Youmba S, Bertiaux-Vandaële N, Antonietti M, Lecleire S, Zalar A, Gourcerol G, Leroi AM, Déchelotte P, Coëffier M, Ducrotté P. PLoS One; 2012; 7(8):e42777. PubMed ID: 23028414 [Abstract] [Full Text] [Related]
3. Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome. Dlugosz A, Zakikhany K, Acevedo N, D'Amato M, Lindberg G. Biomed Res Int; 2017; 2017():9624702. PubMed ID: 28246611 [Abstract] [Full Text] [Related]
4. [Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome]. Wang XM, Liu YL. Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3415-7. PubMed ID: 19159572 [Abstract] [Full Text] [Related]
5. [An investigation of signal transduction pathway of colonic mucosal toll-like receptor 4 in patients with diarrhea-irritable bowel syndrome]. Wang XM, Liu YL. Zhonghua Nei Ke Za Zhi; 2010 Jun 30; 49(6):491-4. PubMed ID: 20979736 [Abstract] [Full Text] [Related]
6. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Miwa J, Echizen H, Matsueda K, Umeda N. Digestion; 2001 Jun 30; 63(3):188-94. PubMed ID: 11351146 [Abstract] [Full Text] [Related]
7. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D. Singh P, Silvester J, Chen X, Xu H, Sawhney V, Rangan V, Iturrino J, Nee J, Duerksen DR, Lembo A. United European Gastroenterol J; 2019 Jun 30; 7(5):709-715. PubMed ID: 31210949 [Abstract] [Full Text] [Related]
8. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome. Willot S, Gauthier C, Patey N, Faure C. Neurogastroenterol Motil; 2012 Aug 30; 24(8):734-9, e347. PubMed ID: 22625872 [Abstract] [Full Text] [Related]
9. [The correlation study between the changes of intestinal mucosa predominant bacteria and Toll-like receptor 2, Toll-like receptor 4 gene expressions in diarrhea-predominant irritable bowel syndrome patients]. Guo WT, Liu P, Dong LN, Wang JP. Zhonghua Nei Ke Za Zhi; 2016 Jul 01; 55(7):541-3. PubMed ID: 27373290 [Abstract] [Full Text] [Related]
10. Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome. Dlugosz A, Nowak P, D'Amato M, Mohammadian Kermani G, Nyström J, Abdurahman S, Lindberg G. Neurogastroenterol Motil; 2015 Dec 01; 27(12):1747-54. PubMed ID: 26387872 [Abstract] [Full Text] [Related]
11. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Am J Gastroenterol; 2006 Jun 01; 101(6):1288-94. PubMed ID: 16771951 [Abstract] [Full Text] [Related]
12. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Szebeni B, Veres G, Dezsõfi A, Rusai K, Vannay A, Mraz M, Majorova E, Arató A. Clin Exp Immunol; 2008 Jan 01; 151(1):34-41. PubMed ID: 17991289 [Abstract] [Full Text] [Related]
13. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Am J Gastroenterol; 2009 Feb 01; 104(2):392-400. PubMed ID: 19174797 [Abstract] [Full Text] [Related]
14. Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance. Qin B, Dong L, Guo X, Jiang J, He Y, Wang X, Li L, Zhao J. Int J Clin Exp Pathol; 2014 Feb 01; 7(5):2238-46. PubMed ID: 24966932 [Abstract] [Full Text] [Related]
15. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome]. Kong WM, Gong J, Dong L, Xu JR. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep 01; 27(9):1345-7. PubMed ID: 17884774 [Abstract] [Full Text] [Related]
17. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? İliaz R, Akyüz F, Yeğen G, Örmeci A, Göktürk S, Akyüz Ü, Baran B, Mutluay Ö, Evirgen S, Karaca Ç, Demir K, Beşışık F, Güllüoğlu M, Kaymakoğlu S. Turk J Gastroenterol; 2018 Jul 01; 29(4):384-391. PubMed ID: 30249551 [Abstract] [Full Text] [Related]
18. [Phenotypic analysis of Th cells in colon and peripheral blood in patients with irritable bowel syndrome]. Fu Y, Tong JJ, Pan Q, Wang WF, Zou KF, Qian W, Hou XH. Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2120-3. PubMed ID: 20058616 [Abstract] [Full Text] [Related]